Lineage Cell Therapeutics
LCTX
LCTX
115 hedge funds and large institutions have $208M invested in Lineage Cell Therapeutics in 2021 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 34 increasing their positions, 15 reducing their positions, and 20 closing their positions.
Holders
115
Holders Change
+13
Holders Change %
+12.75%
% of All Funds
2.01%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
33
Increased
34
Reduced
15
Closed
20
Calls
$818K
Puts
$514K
Net Calls
+$304K
Net Calls Change
+$492K
Top Buyers
1 |
1
BlackRock
New York
|
$24.3M |
2 |
![]()
2
JPMorgan Chase & Co
New York
|
$5.56M |
3 |
3
State Street
Boston,
Massachusetts
|
$5.32M |
4 |
4
Northern Trust
Chicago,
Illinois
|
$4.64M |
5 |
5
Geode Capital Management
Boston,
Massachusetts
|
$6.66M |